


Healthcare News Roundup: Oncology
HSMN NewsFeed - 24 Dec 2018
Varian U.S. Tariff Exclusion Request Granted for Halcyon Radiotherapy System for Cancer Treatments
Varian U.S. Tariff Exclusion Request Granted for Halcyon Radiotherapy System for Cancer Treatments
HSMN NewsFeed - 20 Dec 2018
Merck KGaA, Darmstadt, Germany, Assigns Chimeric Antigen Receptor T-cell (CAR-T) Rights to Intrexon
Merck KGaA, Darmstadt, Germany, Assigns Chimeric Antigen Receptor T-cell (CAR-T) Rights to Intrexon
HSMN NewsFeed - 18 Dec 2018
Erasca Launches with $42 Million Series A Financing to Support Bold Mission of Erasing Cancer
Erasca Launches with $42 Million Series A Financing to Support Bold Mission of Erasing Cancer
HSMN NewsFeed - 13 Dec 2018
Dragonfly Therapeutics Announces Celgene In-license of First Two TriNKET(TM) Immunotherapy Drug Candidates
Dragonfly Therapeutics Announces Celgene In-license of First Two TriNKET(TM) Immunotherapy Drug Candidates
HSMN NewsFeed - 13 Dec 2018
Aethlon Announces Appointment of Timothy Rodell as Interim Chief Executive Officer
Aethlon Announces Appointment of Timothy Rodell as Interim Chief Executive Officer
HSMN NewsFeed - 6 Dec 2018
Accuray CyberKnife(R) System Treatment Delivery Times Up to 50 Percent Faster With Software Upgrade
Accuray CyberKnife(R) System Treatment Delivery Times Up to 50 Percent Faster With Software Upgrade
HSMN NewsFeed - 28 Nov 2018
Q BioMed Inc Announces Acquisition of Cancer Pain Drug Metastron(TM) from GE Healthcare
Q BioMed Inc Announces Acquisition of Cancer Pain Drug Metastron(TM) from GE Healthcare
HSMN NewsFeed - 28 Nov 2018
MabVax Therapeutics Holdings, Inc. Announces $1.0 Million Equity Purchase Agreement
MabVax Therapeutics Holdings, Inc. Announces $1.0 Million Equity Purchase Agreement
HSMN NewsFeed - 21 Nov 2018
OBI Pharma Granted FDA Orphan Drug Designation for OBI-888 for the Treatment of Pancreatic Cancer
OBI Pharma Granted FDA Orphan Drug Designation for OBI-888 for the Treatment of Pancreatic Cancer
HSMN NewsFeed - 19 Nov 2018
RXi Pharmaceuticals Corporation Changes Name to Phio Pharmaceuticals Corp.
RXi Pharmaceuticals Corporation Changes Name to Phio Pharmaceuticals Corp.
HSMN NewsFeed - 14 Nov 2018
Precision BioSciences and MaxCyte Enter into Clinical and Commercial License Agreement
Precision BioSciences and MaxCyte Enter into Clinical and Commercial License Agreement
HSMN NewsFeed - 12 Nov 2018
Arix Bioscience plc: Arix Participates in Harpoon $70m Series C Investment Round
Arix Bioscience plc: Arix Participates in Harpoon $70m Series C Investment Round
